Molecular Imaging Market Will Generate New Growth Opportunities

Market Research Report

A quick peek into the report

1.1 Advent and Evolution of Molecular Imaging
1.1.1 Advantages of Molecular Imaging
1.2 Emerging Trends in Medical Imaging and Impact on Molecular Imaging Market
1.3 Awaited Technological Advancements
1.4 Global Molecular Imaging Market Scenario
1.4.1 Global Molecular Imaging Addressable Market and Future Potential (2018-2029)
1.4.2 Assumptions and Limitations

2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Rising Incidence of Disorders Inciting the use of Molecular Imaging
2.3.2 Utilization of Molecular Imaging to Inform Advances in Precision Medicine
2.3.3 Increased Penetration of Digital Platforms
2.4 Market Restraints
2.4.1 Lack of Specificity for the Diagnosis of Infectious Diseases
2.4.2 Stringent Regulatory Requirements
2.4.3 Poor Reimbursement Scenario
2.5 Market Opportunities
2.5.1 Advent of Multimodality Reporter Genes
2.5.2 Rise in Strategic Collaborations
2.5.3 Significant Technological Advancements in Cardiac Imaging and Oncology

3.1 Key Strategies and Developments (2016-2019)
3.1.1 Joint Ventures, Collaborations, and Partnerships
3.1.2 Mergers and Acquisitions
3.1.3 Product Launches and Enhancements
3.1.4 Awards, Recognitions, and Others
3.1.5 Product Approvals
3.1.6 Business Expansion Activities
3.2 Market Share Analysis
3.2.1 Global Molecular Imaging Systems Market Share Analysis
3.2.2 Global Molecular Imaging Agents Market Share Analysis
3.2.3 Global Molecular Imaging Software Market Share Analysis

4.1 Legal Requirements and Regulations
4.1.1 Regulations in the U.S.
4.1.2 Regulations in Europe
4.1.3 Regulations in Other Countries
4.1.4 Consortiums, Associations, and Regulatory Bodies
4.2 Physicians’ Perception

5.1 Overview
5.2 Imaging Systems
5.2.1 Multimodality Imaging
5.2.2 Radionuclide Imaging
5.2.2.1 Positron Emission Tomography (PET)
5.2.2.2 Single Photon Emission Computed Tomography (SPECT)
5.2.3 Magnetic Resonance Spectroscopy (MRS)
5.2.4 Ultrasound Molecular Imaging
5.2.5 Optical Imaging
5.2.5.1 Fluorescence Imaging
5.2.5.2 Bioluminescence Imaging (BLI)
5.3 Imaging Agents
5.3.1 Small Molecules
5.3.2 Peptides
5.3.3 Antibodies
5.3.4 Aptamers
5.4 Imaging Software

6.1 Overview
6.2 Clinical Applications
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Neurology
6.2.4 Gastroenterology
6.2.5 Other Applications
6.3 Preclinical Research

7.1 Overview
7.2 Hospitals
7.3 Specialty Clinics
7.4 Ambulatory Surgical Centers
7.5 Others

8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Netherlands
8.3.7 Switzerland
8.3.8 Rest-of-Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest-of-Asia-Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest-of-Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 Israel
8.6.3 U.A.E
8.6.4 Rest-of-Middle East and Africa

9.1 Advanced Accelerator Applications
9.1.1 Company Overview
9.1.2 Role of Advanced Accelerator Applications in the Global Molecular Imaging Market
9.1.3 SWOT Analysis: Advanced Accelerator Applications
9.2 Bruker Corporation
9.2.1 Company Overview
9.2.2 Role of Bruker Corporation in the Global Molecular Imaging Market
9.2.3 Financials
9.2.3.1 Key Insights on the Financial Health of the Company
9.2.4 SWOT Analysis: Bruker Corporation
9.3 Canon Inc.
9.3.1 Company Overview
9.3.2 Role of Canon Inc. in the Global Molecular Imaging Market
9.3.3 Financials
9.3.3.1 Key Insights on the Financial Health of the Company
9.3.4 SWOT Analysis: Canon Inc.
9.4 Cardinal Health
9.4.1 Company Overview
9.4.2 Role of Cardinal Health in the Global Molecular Imaging Market
9.4.3 Financials
9.4.4 SWOT Analysis: Cardinal Health
9.5 DDD-Diagnostic A/S
9.5.1 Company Overview
9.5.2 Role of DDD-Diagnostic A/S in the Global Molecular Imaging Market
9.5.3 SWOT Analysis: DDD-Diagnostic A/S
9.6 Digirad Corporation
9.6.1 Company Overview
9.6.2 Role of Digirad Corporation in the Global Molecular Imaging Market
9.6.3 Financials
9.6.3.1 Key Insights on the Financial Health of the Company
9.6.4 SWOT Analysis: Digirad Corporation
9.7 ESAOTE SPA
9.7.1 Company Overview
9.7.2 Role of ESAOTE SPA in the Global Molecular Imaging Market
9.7.3 SWOT Analysis: ESAOTE SPA
9.8 General Electric Company
9.8.1 Company Overview
9.8.2 Role of General Electric Company in the Global Molecular Imaging Market
9.8.3 Financials
9.8.3.1 Key Insights on the Financial Health of the Company
9.8.4 SWOT Analysis: General Electric Company
9.9 Hitachi, Ltd.
9.9.1 Company Overview
9.9.2 Role of Hitachi, Ltd. in the Global Molecular Imaging Market
9.9.3 Financials
9.9.3.1 Key Insights on the Financial Health of the Company
9.9.4 SWOT Analysis: Hitachi, Ltd.
9.10 Koninklijke Philips N.V.
9.10.1 Company Overview
9.10.2 Role of Koninklijke Philips N.V. in the Global Molecular Imaging Market
9.10.3 Financials
9.10.3.1 Key Insights on the Financial Health of the Company
9.10.4 SWOT Analysis: Koninklijke Philips N.V.
9.11 PerkinElmer Inc.
9.11.1 Company Overview
9.11.2 Role of PerkinElmer Inc. in the Global Molecular Imaging Market
9.11.3 Financials
9.11.3.1 Key Insights on the Financial Health of the Company
9.11.4 SWOT Analysis: PerkinElmer Inc.
9.12 Positron Corporation
9.12.1 Company Overview
9.12.2 Role of Positron Corporation in the Global Molecular Imaging Market
9.12.3 SWOT Analysis: Positron Corporation
9.13 Siemens Healthineers AG
9.13.1 Company Overview
9.13.2 Role of Siemens Healthineers AG in the Global Molecular Imaging Market
9.13.3 Financials
9.13.3.1 Key Insights on the Financial Health of the Company
9.13.4 SWOT Analysis: Siemens Healthineers AG
9.14 SurgicEye GmbH
9.14.1 Company Overview
9.14.2 Role of SurgicEye GmbH in the Global Molecular Imaging Market
9.14.3 SWOT Analysis: SurgicEye GmbH
9.15 Thermo Fisher Scientific
9.15.1 Company Overview
9.15.2 Role of Thermo Fisher Scientific in the Global Molecular Imaging Market
9.15.3 Financials
9.15.3.1 Key Insights on the Financial Health of the Company
9.15.4 SWOT Analysis: Thermo Fisher Scientific

10.1 Product Definition
10.2 Scope of Research Study
10.3 Global Molecular Imaging Market: Research Methodology

Table 2.1: Market Drivers
Table: 2.2: Market Restraints
Table 2.3: Currently Used Reporter Genes
Table 4.1: List of Associations/Consortiums/Regulatory Bodies with Year of Establishment, and Region
Table 5.1: FDA Approved Antibody-Based Imaging Agents
Table 8.1: Molecular imaging societies in Rest-of-Europe

Figure 1: Evolution of Molecular Imaging
Figure 2: Impact Analysis of Market Drivers and Market Restraints, 2018-2028
Figure 3: Share of Key Developments and Strategies, January 2015-July 2019
Figure 4: Leading Players in the Global Molecular Imaging Market
Figure 5: Global Molecular Imaging Market, 2018-2028
Figure 6: Global Molecular Imaging Market Share (By Product), 2018 and 2024
Figure 7: Global Molecular Imaging Market Share (By Imaging System), 2018 and 2024
Figure 8: Global Molecular Imaging Market Share (By Imaging Agent), 2018 and 2024
Figure 9: Global Molecular Imaging Market Share (By Clinical Application), 2018 and 2024
Figure 10: Global Molecular Imaging Market Regional Snapshot
Figure 1.1: Types of Molecular Imaging Technologies
Figure 1.2: Evolution of Molecular Imaging
Figure 1.3: Global Molecular Imaging Market, 2018-2028
Figure 3.1: Share of Key Developments and Strategies, January 2015-July 2019
Figure 3.2: Share of Joint Ventures, Collaborations, and Partnerships, January 2015-July 2019
Figure 3.3: Share of Mergers and Acquisitions, January 2015-July 2019
Figure 3.4: Share of Product Launches and Enhancements, January 2015-July 2019
Figure 3.5: Share of Awards, Recognitions, and Others, January 2015-July 2019
Figure 3.6: Share of Product Approvals, January 2015-July 2019
Figure 3.7: Share of Business Expansion Activities, January 2015-July 2019
Figure 3.8: Market Share Analysis: Global Molecular Imaging Market, 2018
Figure 3.9: Market Share Analysis: Global Molecular Imaging Market, 2017
Figure 3.10: Market Share Analysis: Global Molecular Imaging Market (by Systems), 2018
Figure 3.11: Market Share Analysis: Global Molecular Imaging Market (by Systems), 2017
Figure 3.12: Market Share Analysis: Global Molecular Imaging Market (by Imaging Agents), 2018
Figure 3.13: Market Share Analysis: Global Molecular Imaging Market (by Imaging Agents), 2017
Figure 3.14: Market Share Analysis: Global Molecular Imaging Market (by Imaging Software), 2018
Figure 3.15: Market Share Analysis: Global Molecular Imaging Market (by Imaging Software), 2017
Figure 5.1: Global Molecular Imaging Market (by Product), 2018-2028
Figure 5.2: Type of Molecular Imaging Systems
Figure 5.3: Global Molecular Imaging Market (by Imaging Systems), 2018-2028
Figure 5.4: Global Molecular Imaging Market (by Imaging Systems), 2018-2028
Figure 5.5: Global Molecular Imaging Market (by Multimodality Imaging), 2018-2028
Figure 5.6: Types of Multimodality Imaging Systems
Figure 5.7: Global Molecular Imaging Market (by Radionuclide Imaging), 2018-2028
Figure 5.8: Types of Radionuclide Imaging Systems
Figure 5.9: Global Molecular Imaging Market (by MRS), 2018-2028
Figure 5.10: Global Molecular Imaging Market (by Ultrasound Molecular Imaging), 2018-2028
Figure 5.11: Global Molecular Imaging Market (by Optical Imaging), 2018-2028
Figure 5.12: Types of Optical Imaging Systems
Figure 5.13: Type of Molecular Imaging Agents
Figure 5.14: Global Molecular Imaging Market (by Imaging Systems), 2018-2028
Figure 5.15: Global Molecular Imaging Market (by Imaging Agents), 2018-2028
Figure 5.16: Global Molecular Imaging Market (by Small Molecules), 2018-2028
Figure 5.17: Global Molecular Imaging Market (by Peptides), 2018-2028
Figure 5.18: Global Molecular Imaging Market (by Antibodies), 2018-2028
Figure 5.19: Global Molecular Imaging Market (by Aptamers), 2018-2028
Figure 5.20: Global Molecular Imaging Market (by Imaging Software), 2018-2028
Figure 6.1: Global Molecular Imaging Market (by Application), 2018-2028
Figure 6.2: Global Molecular Imaging Market (by Clinical Applications), 2018-2028
Figure 6.3: Global Molecular Imaging Market (by Clinical Applications), 2018-2028
Figure 6.4: Global Molecular Imaging Market (by Oncology), 2018-2028
Figure 6.5: Global Molecular Imaging Market (by Cardiology), 2018-2028
Figure 6.6: Global Molecular Imaging Market (by Neurology), 2018-2028
Figure 6.7: Global Molecular Imaging Market (by Gastroenterology), 2018-2028
Figure 6.8: Global Molecular Imaging Market (by Other Applications), 2018-2028
Figure 6.9: Global Molecular Imaging Market (by Preclinical Research), 2018-2028
Figure 7.1: Global Molecular Imaging Market (by End User), 2018-2028
Figure 7.2: Global Molecular Imaging Market (by Hospitals), 2018-2028
Figure 7.3: Global Molecular Imaging Market (by Specialty Clinics), 2018-2028
Figure 7.4: Global Molecular Imaging Market (Ambulatory Surgical Centers), 2018-2028
Figure 7.5: Global Molecular Imaging Market (by Others), 2018-2028
Figure 8.1: Global Molecular Imaging Market Scenario, 2018 and 2028
Figure 8.2: North America: Molecular Imaging Market, 2018-2028
Figure 8.3: North America: Market Dynamics
Figure 8.4: North America: Molecular Imaging Market (by Country), 2018 and 2028
Figure 8.5: The U.S.: Molecular Imaging Market, 2018-2028
Figure 8.6: Canada: Molecular Imaging Market, 2018-2028
Figure 8.7: Europe: Molecular Imaging Market, 2018-2028
Figure 8.8: Europe: Market Dynamics
Figure 8.9: Europe: Molecular Imaging Market (by Country), 2018 and 2028
Figure 8.10: Germany: Molecular Imaging Market, 2018-2028
Figure 8.11: The U.K.: Molecular Imaging Market, 2018-2028
Figure 8.12: France: Molecular Imaging Market, 2018-2028
Figure 8.13: Italy: Molecular Imaging Market, 2018-2028
Figure 8.14: Spain: Molecular Imaging Market, 2018-2028
Figure 8.15: The Netherlands: Molecular Imaging Market, 2018-2028
Figure 8.16: Switzerland: Molecular Imaging Market, 2018-2028
Figure 8.17: Rest-of-Europe: Molecular Imaging Market, 2018-2028
Figure 8.18: Asia-Pacific: Molecular Imaging Market, 2018-2028
Figure 8.19: Asia-Pacific: Market Dynamics
Figure 8.20: Asia-Pacific: Molecular Imaging Market, 2018-2028
Figure 8.21: China: Molecular Imaging Market, 2018-2028
Figure 8.22: Japan: Molecular Imaging Market, 2018-2028
Figure 8.23: India: Molecular Imaging Market, 2018-2028
Figure 8.24: Australia: Molecular Imaging Market, 2018-2028
Figure 8.25: South Korea: Molecular Imaging Market, 2018-2028
Figure 8.26: Rest-of-Asia-Pacific: Molecular Imaging Market, 2018-2028
Figure 8.27: Latin America: Molecular Imaging Market, 2018-2028
Figure 8.28: Latin America: Market Dynamics
Figure 8.29: Latin America: Molecular Imaging Market, 2018-2028
Figure 8.30: Brazil: Molecular Imaging Market, 2018-2028
Figure 8.31: Mexico: Molecular Imaging Market, 2018-2028
Figure 8.32: Argentina: Molecular Imaging Market, 2018-2028
Figure 8.33: Rest-of-Latin America: Molecular Imaging Market, 2018-2028
Figure 8.34: Middle East and Africa: Molecular Imaging Market, 2018-2028
Figure 8.35: Middle East and Africa: Market Dynamics
Figure 8.36: Middle East and Africa: Molecular Imaging Market, 2018-2028
Figure 8.37: Saudi Arabia: Molecular Imaging Market, 2018-2028
Figure 8.38: Israel: Molecular Imaging Market, 2018-2028
Figure 8.39: U.A.E: Molecular Imaging Market, 2018-2028
Figure 8.40: Rest-of-Middle East and Africa: Molecular Imaging Market, 2018-2028
Figure 9.1: Shares of Key Company Profiles
Figure 9.2: Advanced Accelerator Applications: Product Offerings for the Global Molecular Imaging Market
Figure 9.3: Bruker Corporation: Product Offerings for the Global Molecular Imaging Market
Figure 9.4: Bruker Corporation: Overall Financials, 2016-2018
Figure 9.5: Bruker Corporation Net Revenue (by Business Segment), 2016-2018
Figure 9.6: Bruker Corporation Net Revenue (by Business Sub-Segment), 2016-2018
Figure 9.7: Bruker Corporation: Net Revenue (by Region), 2016-2018
Figure 9.8: Bruker Corporation: R&D Expense, 2016-2018
Figure 9.9: Canon Inc.: Product Offerings for the Global Molecular Imaging Market
Figure 9.10: Canon Inc.: Overall Financials, 2016-2018
Figure 9.11: Canon Inc. Net Revenue (by Business Segment), 2016-2018
Figure 9.12: Canon Inc.: Net Revenue (by Region), 2016-2018
Figure 9.13: Canon Inc.: R&D Expense, 2016-2018
Figure 9.14: Cardinal Health: Product Offerings for the Global Molecular Imaging Market
Figure 9.15: Cardinal Health: Overall Financials, 2016-2018
Figure 9.16: Cardinal Health Net Revenue (by Business Segment), 2016-2018
Figure 9.17: Cardinal Health: Net Revenue (by Region), 2016-2018
Figure 9.18: DDD-Diagnostic A/S: Product Offerings for the Global Molecular Imaging Market
Figure 9.19: Digirad Corporation: Product Offerings for the Global Molecular Imaging Market
Figure 9.20: Digirad Corporation: Overall Financials, 2016-2018
Figure 9.21: Digirad Corporation Net Revenue (by Business Segment), 2016-2018
Figure 9.22: Digirad Corporation: Net Revenue (by Region), 2016-2018
Figure 9.23: ESAOTE SPA: Product Offerings for the Global Molecular Imaging Market
Figure 9.24: General Electric Company: Product Offerings for Global Molecular Imaging Market
Figure 9.25: General Electric Company: Overall Financials, 2016-2018
Figure 9.26: General Electric Company Net Revenue (by Business Segment), 2016-2018
Figure 9.27: General Electric Company: Net Revenue (by Region), 2016-2018
Figure 9.28: General Electric Company: R&D Expense, 2016-2018
Figure 9.29: Hitachi, Ltd.: Product Offerings for the Global Molecular Imaging Market
Figure 9.30: Hitachi, Ltd.: Overall Financials, 2016-2018
Figure 9.31: Hitachi, Ltd. Net Revenue (by Business Segment), 2016-2018
Figure 9.32: Hitachi, Ltd.: Net Revenue (by Region), 2016-2018
Figure 9.33: Hitachi, Ltd.: R&D Expense, 2016-2018
Figure 9.34: Koninklijke Philips N.V.: Product Offerings for the Global Molecular Imaging Market
Figure 9.35: Koninklijke Philips N.V.: Overall Financials, 2016-2018
Figure 9.36: Koninklijke Philips N.V. Net Revenue (by Business Segment), 2016-2018
Figure 9.37: Koninklijke Philips N.V.: Net Revenue (by Region), 2016-2018
Figure 9.38: Koninklijke Philips N.V.: R&D Expense, 2016-2018
Figure 9.39: PerkinElmer Inc.: Product Offerings for the Global Molecular Imaging Market
Figure 9.40: PerkinElmer Inc.: Overall Financials, 2016-2018
Figure 9.41: PerkinElmer Inc. Net Revenue (by Business Segment), 2016-2018
Figure 9.42: PerkinElmer Inc.: Net Revenue (by Region), 2016-2018
Figure 9.43: PerkinElmer Inc.: R&D Expense, 2016-2018
Figure 9.44: Positron Corporation: Product Offerings for the Global Molecular Imaging Market
Figure 9.45: Siemens Healthineers AG: Product Offerings for the Global Molecular Imaging Market
Figure 9.46: Siemens Healthineers AG: Overall Financials, 2016-2018
Figure 9.47: Siemens Healthineers AG Net Revenue (by Business Segment), 2016-2018
Figure 9.48: Siemens Healthineers AG: Net Revenue (by Region), 2016-2018
Figure 9.49: Siemens Healthineers AG: R&D Expense, 2016-2018
Figure 9.50: SurgicEye GmbH: Product Offerings for the Global Molecular Imaging Market
Figure 9.51: Thermo Fisher Scientific: Product Offerings for the Global Molecular Imaging Market
Figure 9.52: Thermo Fisher Scientific: Overall Financials, 2016-2018
Figure 9.53: Thermo Fisher Scientific Net Revenue (by Business Segment), 2016-2018
Figure 9.54: Thermo Fisher Scientific: Net Revenue (by Region), 2016-2018
Figure 9.55: Thermo Fisher Scientific: R&D Expense, 2016-2018
Figure 10.1: Global Molecular Imaging Market Segmentation
Figure 10.2: Research Methodology
Figure 10.3: Primary Research
Figure 10.4: Secondary Research
Figure 10.5: Data Triangulation
Figure 10.6: Bottom-up Approach (Segment-wise Analysis)
Figure 10.7: Top-Down Approach (Segment-wise Analysis)
Figure 10.8: Assumptions and Limitations
Figure 10.9: Considered Factors for Data Prediction and Modeling

Market Overview

Global Molecular Imaging Market Value and Estimation

As per the global molecular imaging market analysis conducted by BIS Research, the market was valued at approximately $6.84 billion in 2018 and is anticipated to reach $11.13 billion by 2028. Presently, the incidence of chronic disorders such as cardiovascular, oncological, and neurological disorders is rising at alarming rates and is creating an increased economic burden on the healthcare providers and the patients.

To combat the growing incidence and to reduce the costs associated with disease management healthcare providers as well as the researchers are promoting and identifying novel methods for preventive care and early detection. Molecular imaging is one such highly advanced method in the field of medical imaging which allows the functional diagnosis and aids in the characterization of the physiological events at the cellular and molecular level.

Expert Quote on Global Molecular Imaging Market

“North America is currently the leading contributor to the molecular imaging market. The market was valued $3.89 billion in 2018. Factors such as rising demand for minimally invasive surgeries, increasing cases of chronic diseases, approval of novel radiotracers, and the growing awareness regarding molecular imaging are driving the growth of the North American molecular imaging market. However, the Asia-Pacific is expected to register the highest CAGR of 6.68% during the forecast period 2019-2028”.

Key Questions Answered in this Report

• What is the total market size at present and forecast for global molecular imaging market by 2028?
• What are the current key trends witnessed by the global molecular imaging market?
• What are the key market dynamics i.e. drivers, restraints, and opportunities for molecular imaging market?
• How would artificial intelligence-enabled image analytics result in a dynamic shift in the growth of molecular imaging market during the forecast period?
• What are the key strategies incorporated by the leading players of molecular imaging market?
• What is the market share of key competitors for the product categories?
• What are the regulations influencing molecular imaging market, across regions?
• What is the current total market size and the forecast for different product categories available in molecular imaging market by 2028?
• How would imaging agents evolve to be dominating contributors in the global molecular imaging market revenue and why?
• What is the current total market estimation and forecasts of molecular imaging products across different countries by 2028?

Report Description

Scope of the Market Intelligence on Global Molecular Imaging Market

The purpose of the study is to gain a holistic view of the molecular imaging market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the products allied with the molecular imaging market, which include imaging systems, imaging agents, and imaging software.

The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

Market Segmentation

The global molecular imaging market is segmented into four different parts: by product, by application, by end user, and by region. The global market value was estimated using these three different approaches and was validated with one another. These segments are further segmented into several sub-segments to ease the market estimation.

With the increasing incidence of chronic disorders, increased digital platform penetration, and the increased utilization of molecular imaging in disciplines such as precision medicine the molecular imaging market is expected to witness a gradual growth. Moreover, the ongoing technological advancements have led to the identification of multimodality molecular imaging technology as an innovative approach for the functional as well as anatomical diagnosis.

The use of multimodality imaging techniques including PET-MRI, PET-CT, and SPECT-CT is becoming increasingly prevalent attributed to which the multimodality imaging technology is expected to dominate the market. Moreover, with the advent of novel imaging agents including the multimodality reporter genes is expected to expand the clinical application of techniques such as optical imaging and targeted molecular ultrasound because of which these segments are expected to witness an impressive CAGR during the forecast period.

The global molecular imaging market is segmented by the geographical regions into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is the leading contributor to the global molecular imaging market followed by Europe. However, the Asia-Pacific region is expected to register a highest CAGR during the forecast period.

The global molecular imaging market is dominated by the U.S. and the European players. The U.S.-based companies, Cardinal Health and General Electric Company and the European companies Siemens Healthcare GmbH and Koninklijke Philips N.V. GmbH accounted for more than 70% of the market value in 2018.

Key Players in the Market

The key players who have significant contributions to the global molecular imaging equipment market are Advanced Accelerator Applications, Bruker Corporation, Canon Inc., Digirad Corporation, ESAOTE SPA, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V. GmbH, PerkinElmer Inc., Positron Corporation, Siemens Healthcare GmbH, SurgicEye GmbH, and Thermo Fisher Scientific, among others.

Global Molecular Imaging Market – Analysis and Forecast, 2019-2028

Focus on Equipment, Software, Imaging Agents, Applications, End Users, 20 Countries’ Data and Competitive Landscape

Get Free Sample

Schedule a Call

A quick peek into the report